Key result
Metabolically healthy obesity defined by a novel criterion was not associated with a significantly increased risk of composite cardiovascular events compared to metabolically healthy non-obesity (HR 1.15).
Why the study?
Whether individuals with metabolically healthy obesity (MHO) have a lower cardiovascular risk remains controversial, prompting evaluation of a new diagnostic criterion for MHO compared to traditional criteria.
Does metabolically healthy obesity defined by a novel criterion predict a lower risk of cardiovascular events compared to traditional criteria in adults without baseline cardiovascular disease?
Cohort (n=9,345)
Yes
Does metabolically healthy obesity defined by a novel criterion predict a lower risk of cardiovascular events compared to traditional criteria in adults without baseline cardiovascular disease?
Hazard Ratio: 1.15 (95% CI 0.67–1.99)
Absolute Event Rate: 2.14% vs 2.03%
New MHO criterion may refine CV risk stratification in obesity; leaves open whether it improves prediction over standard definitions.
Background and objective Obesity has become a serious public health problem and brings a heavy burden of cardiovascular disease. Metabolically healthy obesity (MHO) is defined as individuals with obesity with no or only minor metabolic complications. Whether individuals with MHO have a lower cardiovascular risk remains controversial. In this study, a new criterion was used to define MHO and assess its predictive value for cardiovascular events and death. At the same time, the new criterion and the traditional criterion are compared to analyze the differences between different diagnostic criteria. Methods A prospective cohort was established in northeast rural China from 2012 to 2013. Follow-up was conducted in 2015 and 2018 to investigate the incidence of cardiovascular events and survival. Subjects were grouped according to the metabolic health and obesity status. Kaplan-Meier curves were drawn to describe the cumulative risk of endpoint events in the four groups. Cox regression analysis model was constructed to evaluate the risk of endpoint events. Analysis of variance and post hoc analyses were used to calculate and compare differences in metabolic markers between MHO subjects diagnosed by novel and traditional criteria. Results A total of 9345 participants 35 years of age or older without a history of cardiovascular disease were included in this study. After a median follow-up of 4.66 years, the data showed that participants in the MHO group had no significant increase in the risk of composite cardiovascular events and stroke, but had a 162% increase in the risk of coronary heart disease (HR: 2.62; 95%CI: 1.21-5.67). However, when using conventional criteria for metabolic health, mMHO group had a 52% increase in combined CVD risk (HR: 1.52; 95%CI: 1.14-2.03). By comparing the differences of metabolic indicators between MHO subjects diagnosed by the two criteria, MHO subjects diagnosed by the new criterion had higher WC, WHR, TG, FPG, and lower HDL-C levels except for lower blood pressure, showing more exposure to cardiovascular risk factors. Conclusions The risk of combined CVD and stroke was not increased in MHO subjects. The new metabolic health criterion is superior to the traditional criterion and can effectively identify individuals with obesity with a lower risk of combined CVD. Blood pressure levels may be responsible for the inconsistent risk of combined CVD in MHO subjects diagnosed with both criteria.
No takes yet. Share an insight, caveat, or question.
Li et al. (2023) conducted a cohort in Metabolically healthy obesity (MHO) and cardiovascular risk (n=9,345). Metabolically healthy obesity (MHO) defined by a novel criterion vs. Metabolically healthy non-obesity (MHN) was evaluated on Incident composite cardiovascular disease (fatal and non-fatal stroke and CHD) (HR 1.15, 95% CI 0.67-1.99). Metabolically healthy obesity defined by a novel criterion was not associated with a significantly increased risk of composite cardiovascular events compared to metabolically healthy non-obesity (HR 1.15).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: